MedTrace Logo

MASCOT Registry of Patients With Myeloproliferative Neoplasms Associated Splanchnic Vein Thrombosis

NCT04994158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 238

Last updated 2025-07-30

No results posted yet for this study

Summary

A registry of UK patients diagnosed to have splanchnic vein thrombosis and myeloproliferative neoplasm, including isolated mutation of JAK2V617f. The purpose of the registry is to understand outcomes, treatment variations and data to inform and enable future clinical trial design and facilitate regulatory approval decision-making.

Conditions

  • Myeloproliferative Neoplasm
  • Splanchnic Vein Thrombosis
  • JAK2 V617

Interventions

COMBINATION_PRODUCT

Drugs, procedures

standard of care only. non interventional registry.

Sponsors & Collaborators

  • Royal Free Hospital NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2023-09-21
Completion
2023-09-21

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04994158 on ClinicalTrials.gov